A patient receives morphine for postoperative pain relief. The analgesic effect is mediated primarily through which spinal cord pathway and mechanism?

## Opioid Analgesia: Spinal Mechanisms **Key Point:** Morphine and other opioids produce analgesia by activating μ-opioid receptors at two critical sites in the dorsal horn: presynaptic nociceptive terminals (reducing transmitter release) and postsynaptic pain-relay neurons (hyperpolarizing them). ### Dual-Site Mechanism of Opioid Action ```mermaid flowchart TD A[Morphine binds μ-opioid receptor]:::action --> B{Location?}:::decision B -->|Presynaptic terminal| C[Inhibits substance P release<br/>from C-fiber and Aδ-fiber]:::outcome B -->|Postsynaptic neuron| D[Hyperpolarizes pain-relay neuron<br/>Opens K+ channels]:::outcome C --> E[Reduced nociceptive signal<br/>transmission]:::action D --> E E --> F[Analgesia]:::outcome ``` ### Receptor Specificity **High-Yield:** μ-opioid receptors are the primary mediators of analgesia. δ and κ receptors contribute to analgesia but are less potent and have different distributions. ### Distinction from Other Analgesic Pathways | Pathway | Neurotransmitter | Mechanism | Clinical Use | |---|---|---|---| | **Opioid (spinal)** | Endogenous enkephalins; exogenous morphine | μ-receptor activation (pre- and postsynaptic) | Strong analgesia, opioid-responsive pain | | **Descending noradrenergic** | Norepinephrine from locus coeruleus | α~2~-adrenergic receptors; modulates pain | Adjuvant (e.g., dexmedetomidine) | | **NMDA blockade** | Glutamate antagonism | Prevents central sensitization | Ketamine (dissociative anesthetic) | | **Glycinergic** | Glycine in substantia gelatinosa | Postsynaptic inhibition | Minor role in spinal analgesia | **Clinical Pearl:** Opioid analgesia is most effective for nociceptive pain (somatic and visceral) and less effective for neuropathic pain, where NMDA receptor antagonists (ketamine) or noradrenergic agents (duloxetine) may be more useful.